/Companies

Lattice Therapeutics

Washington, US · Founded 2020 · Delaware corporation

Find your way into Lattice Therapeutics

Sign up to see every warm intro you have to Lattice Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Lattice Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

PM
Patrick Michael McTamneyNamed on SEC filing
JG
Jack Guy DaSilvaNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$300K disclosed across 1 round · 2022

▶$300KraisedJun 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick Michael McTamneyExecutive Officer, Director
  • Jack Guy DaSilvaDirector
Offering amount
$900K
Amount sold
$300K
First sale
May 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Lattice Therapeutics raised?
Lattice Therapeutics has disclosed $300K raised across 1 round.
Where is Lattice Therapeutics headquartered?
Lattice Therapeutics is headquartered in Washington, US.